Lanean...

Part 2: Introduction to the Pharmacotherapy of Parkinson’s Disease, With a Focus on the Use of Dopaminergic Agents

This second of five articles reviews Parkinson’s disease pharmacotherapy, focusing on dopaminergic agents such as levodopa/carbidopa and dopamine receptor agonists.

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:P T
Egile Nagusiak: DeMaagd, George, Philip, Ashok
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MediMedia USA, Inc. 2015
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4571848/
https://ncbi.nlm.nih.gov/pubmed/26417179
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!